Second Primary Malignancy Incidence in Patients Receiving Lenalidomide at Induction and Maintenance; Long-Term Follow up of 4358 Patients Enrolled to the Myeloma XI Trial

Autor: Jones, John R ^{1, 2, 3, 4, *}, Cairns, David ^{5, *}, Menzies, Tom ^{5, *}, Pawlyn, Charlotte ^{6, 7}, Davies, Faith E. ^{8, *}, Sigsworth, Rachel ^{5, *}, Jenner, Matthew W ^{9, *}, Kaiser, Martin F. ^{10, 11}, Mottram, Rebecca ^{5, *}, Drayson, Mark T ^{12, *}, Gregory, Walter Martin ^{5, *}, Owen, Roger G ^{13, *}, Boyd, Kevin ^{11, *}, Cook, Gordon ^{14, *}, Jackson, Graham ¹⁵, Morgan, Gareth J. ¹⁶

Publikováno v: In Blood 15 November 2022 140 Supplement 1:1823-1825

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Thrombosis in Patients with Myeloma Treated in the Myeloma IX and Myeloma XI Phase III Randomized Controlled Trials

Autor: Bradbury, Charlotte A, Craig, Zoe, Cook, Gordon, Pawlyn, Charlotte, Cairns, David A, Hockaday, Anna, Paterson, Andrea, Jenner, Matthew W, Jones, John Robert, Drayson, Mark Trehane, Owen, Roger G, Kaiser, Martin F, Gregory, Walter Martin, Davies, Faith E, Child, James Anthony, Morgan, Gareth J, Jackson, Graham

Publikováno v: Bradbury, C A, Craig, Z, Cook, G, Pawlyn, C, Cairns, D A, Hockaday, A, Paterson, A, Jenner, M W, Jones, J R, Drayson, M T, Owen, R G, Kaiser, M F, Gregory, W M, Davies, F E, Child, J A, Morgan, G J & Jackson, G 2020, ' Thrombosis in Patients with Myeloma Treated in the Myeloma IX and Myeloma XI Phase III Randomized Controlled Trials ', Blood, vol. 136, no. 9, pp. 1091-1104 . https://doi.org/10.1182/blood.2020005125

Newly diagnosed multiple myeloma (NDMM) patients treated with immunomodulatory drugs (IMiDs) are at high venous thrombosis (VTE) risk, but data are lacking from large prospective cohorts. We present thrombosis outcome data from Myeloma IX (n=1936) an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2642::444e203f83fb2f2a9c089a5b5ddc0387
https://research-information.bris.ac.uk/ws/files/232642447/7.4.20_revised_Myeloma_IX_and_XI_thrombosis.pdf

The Impact of Autologous Stem Cell Transplantation on the Genetics of High-Risk Relapsed Multiple Myeloma

Autor: Shahin, Mohamed ^{1, *}, Pawlyn, Charlotte ^{2, 3}, Weinhold, Niels ^{4, *}, Ashby, Timothy Cody ^{5, *}, Walker, Brian A. ⁶, Wardell, Christopher P. ^{7, *}, Cairns, David ^{8, *}, Menzies, Tom ^{9, *}, Gregory, Walter Martin ^{9, *}, Kaiser, Martin F. ^{10, 3}, Cook, Gordon ^{11, *}, Drayson, Mark T ^{12, *}, Owen, Roger G ^{13, *}, Jackson, Graham ¹⁴, Davies, Faith E ¹⁵, Morgan, Gareth J. ¹⁵, Jones, John R ^{16, 17, 18, *}

Publikováno v: In Blood 15 November 2022 140 Supplement 1:4232-4233